Work

Faculty Opinions recommendation of Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

Year: 2009

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.1162355.622853

Authors: Keith Flaherty, Stephen Keefe

Institutions: Massachusetts General Hospital, University of Pennsylvania

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4234330342

Cites:

Cited by:

Related to: 10